TickerFacts.

Company research / MDT

Medtronic plc (MDT)

Build a valuation ↗↓ Download CSV

CIK 0001613103 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Fiscal year ends around Apr 24

For the year ended 2026-04-24, Medtronic plc reported revenue of $36.36B. Revenue grew 8.4% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $37.54B.

Key ratios (year ended 2026-04-24)

65.0%
Gross margin (computed)
17.8%
Operating margin
13.2%
Net margin
9.7%
Return on year-end equity
8.4%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-21

Headquarters locality: Ireland / Fridley · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-31		2026-04-242025-04-252024-04-262023-04-282022-04-292021-04-302020-04-242019-04-262018-04-272017-04-28
Revenue$37.54B$36.36B$33.54B$32.36B$31.23B$31.69B$30.12B$28.91B$30.56B$29.95B$29.71B
Cost of Revenue$13.14B$12.72B$11.63B$11.22B$10.72B$10.14B$10.48B$9.42B$9.15B$9.07B$9.29B
Gross Profit$24.41B$23.64B$21.91B$21.15B$20.51B$21.54B$19.63B$19.49B$21.40B$20.90B$20.42B
R&D Expense$2.92B$2.87B$2.73B$2.73B$2.70B$2.75B$2.49B$2.33B$2.33B$2.26B$2.19B
Operating Income$6.79B$6.47B$5.96B$5.14B$5.49B$5.75B$4.48B$4.79B$6.27B$6.64B$5.38B
Depreciation & Amortization$2.94B$2.96B$2.86B$2.65B$2.70B$2.71B$2.70B$2.66B$2.66B$2.64B$2.92B
EBITDA$9.72B$9.43B$8.82B$7.79B$8.18B$8.46B$7.19B$7.45B$8.93B$9.28B$8.30B
Net Income$5.23B$4.80B$4.66B$3.68B$3.76B$5.04B$3.61B$4.79B$4.63B$3.10B$4.03B
EPS (Diluted)n/a$3.73$3.61$2.76$2.82$3.73$2.66$3.54$3.41$2.27$2.89
Total Assets$93.31B$93.03B$91.68B$89.98B$90.95B$90.98B$93.08B$90.69B$89.69B$91.39B$99.86B
Total Liabilities$42.46B$42.96B$43.42B$39.56B$39.28B$38.26B$41.48B$39.82B$39.48B$40.57B$49.53B
Shareholders' Equity$50.23B$49.46B$48.02B$50.21B$51.48B$52.55B$51.43B$50.74B$50.09B$50.72B$50.21B
Cash & Equivalents$1.69B$1.95B$2.22B$1.28B$1.54B$3.71B$3.59B$4.14B$4.39B$3.67B$4.97B
Operating Cash Flow$8.04B$7.33B$7.04B$6.79B$6.04B$7.35B$6.24B$7.23B$7.01B$4.68B$6.88B
Capital Expenditures$1.90B$1.90B$1.86B$1.59B$1.46B$1.37B$1.35B$1.21B$1.13B$1.07B$1.25B
Free Cash Flow$6.13B$5.43B$5.18B$5.20B$4.58B$5.98B$4.88B$6.02B$5.87B$3.62B$5.63B
Share Repurchases$1.18B$1.03B$3.23B$2.14B$645.00M$2.54B$652.00M$1.33B$2.88B$2.17B$3.54B
Dividends Paid$3.65B$3.64B$3.59B$3.67B$3.62B$3.38B$3.12B$2.89B$2.69B$2.49B$2.38B
Shares Outstanding1.28B1.28B1.28B1.31B1.33B1.33B1.35B1.34B1.34B1.35B1.37B
Dividends Per Sharen/a$2.84$2.80$2.76$2.72$2.52$2.32$2.16$2.00$1.84$1.72
Weighted Average Diluted Sharesn/a1.29B1.29B1.33B1.33B1.35B1.35B1.35B1.36B1.37B1.39B
EPS (Basic)n/a$3.75$3.63$2.77$2.83$3.75$2.68$3.57$3.44$2.29$2.92

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView